For the Culture By The Culture. ISSN: 3064-9331.
Ohio voters approved adult use cannabis with 57 percent support in 2023. Two years later, lawmakers narrowed that framework through Senate Bill 56. A referendum campaign now seeks to overturn those revisions, requiring roughly 248,000 valid signatures statewide. This piece breaks down what changed, who changed it, and what voters are being asked to decide next.
Actor David Krumholtz’s experience with Cannabinoid Hyperemesis Syndrome sparked a backlash that reveals a deeper problem in cannabis culture. This piece examines how rare conditions get weaponized, why defensive reactions backfire, and how patients, veterans, and families are erased when nuance collapses on both sides of the cannabis debate.
Federal officials claim cannabis is moving forward, but Schedule III changes nothing that matters. This investigation breaks down what rescheduling actually does, what it deliberately avoids, and why prohibition logic remains intact. Arrests continue. Markets remain conflicted. Reform language replaces reform action. The system shifts labels while preserving control.
Hospitals increasingly diagnose Cannabinoid Hyperemesis Syndrome without testing the cannabis products involved. This investigation examines how cartridges, edibles, and other cannabis materials are excluded from medical evaluation, despite known contamination risks, leaving patients with diagnoses based on symptoms and self reported use rather than verified evidence.
Cannabis rescheduling keeps resurfacing in headlines, then vanishes without action. This feature breaks down how federal officials repeatedly float reform language, let deadlines pass, and leave the law untouched. By tracing the mechanics behind the stall, the piece exposes why delay is intentional, who benefits from it, and why cannabis reform remains trapped in federal limbo.
This week’s Reefer Report Card exposes a system under strain as federal hemp policy whiplashes, New York’s cannabis regulator unravels, and Massachusetts stirs panic over THC potency. Patients and workers absorb the fallout while international reform stalls under bureaucratic drag. Cannabis holds steady. Governance does not.
